Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with ...

Pfizer Inc. (NYSE: PFE) today announced updated follow-up results from the single-arm Phase 2 PHAROS trial evaluating ...

Mercer Trades For A Price Because Its Financial Risk Is Real And Near

Mercer International's valuation appears attractive if a cyclical recovery occurs. Read here to know if MERC stock is a smart ...